Federal Register / Vol. 70, No. 181 / Tuesday, September 20, 2005 / Notices 55177 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 030–02286] 

Issuance of Environmental 

Assessment and Finding of No 

Significant Impact Regarding a 

Proposed License No. 24–00889–01 

Amendment for Saint Luke’s Hospital 

of Kansas City, Kansas City, MO 

AGENCY: Nuclear Regulatory 

Commission (NRC). 

ACTION: Issuance of environmental 

assessment and finding of no significant 

impact. 

FOR FURTHER INFORMATION CONTACT: 

Gene Bonano, Health Physicist, 

Decommissioning Branch, Division of 

Nuclear Material Safety, Region III, U.S. 

Nuclear Regulatory Commission, 2443 

Warrenville Road, Lisle, Illinois 60532; 

Telephone: (630) 829–9826; fax number: 

(630) 515–1259; e-mail: gab1@nrc.gov. 

SUPPLEMENTARY INFORMATION: The 

Nuclear Regulatory Commission (NRC) 

is considering the issuance of an 

amendment to Material License No. 24–

00889–01 to authorize Saint Luke’s 

Hospital of Kansas City, Kansas City, 

Missouri (the licensee), to release from 

its license the Medical Plaza I Building 

at 4320 Wornall Road, and the DicksonDiveley Laboratory at 4312 J.C. Nichols 

Parkway, Kansas City, Missouri for 

unrestricted use. The NRC has prepared 

this Environmental Assessment (EA) in 

support of this proposed action in 

accordance with the requirements of 10 

CFR Part 51. Based on this EA, the NRC 

has determined that a Finding of No 

Significant Impact (FONSI) is 

appropriate. 

I. Environmental Assessment 

Identification of the Proposed Action 

The proposed action would approve 

the licensee’s request to amend its 

license to release the Medical Plaza I 

Building and the Dickson-Diveley 

Laboratory from its license for 

unrestricted use in accordance with 10 

CFR part 20, subpart E. The proposed 

action is in accordance with the 

licensee’s December 1, 2004 

(ML052510691) and June 21, 2005 

(ML052510686) request to release its 

Medical Plaza I Building and DicksonDiveley Laboratory for unrestricted use. 

Both facilities are listed under Saint 

Luke’s Material License Number 24–

00889–01. Saint Luke’s Hospital is 

authorized to use byproduct material for 

medical research. The licensee 

transferred all licensed material from 

the Medical Plaza I Building and the 

Dickson-Diveley Laboratory to its 

radioactive waste storage area in the 

main hospital building. The main 

hospital building is under the same 

radioactive materials license. The 

licensee also transferred materials to the 

Mayo Clinic Rochester [License No. 22–

00519–03], and shipped material for 

disposal through Adco Services, Inc. 

[IL–01347–01], and GTS Duratek [R–

73008–E94]. The licensee identified two 

isotopes, which are listed in the license, 

with half-lives greater than 120 days 

(hydrogen–3, and carbon–14), which 

had been used at the Medical Plaza I 

Building and Dickson-Diveley 

Laboratory facilities. The licensee 

conducted surveys of the facilities and 

provided information to the NRC to 

demonstrate that the radiological 

condition of the buildings is consistent 

with criteria specified in 10 CFR part 

20, subpart E for unrestricted use. No 

radiological remediation activities are 

required to complete the proposed 

action. 

Need for the Proposed Action 

The licensee is requesting this license 

amendment because it no longer plans 

to conduct NRC-licensed activities at 

the Medical Plaza I Building and the 

Dickson-Diveley Laboratory. The NRC is 

fulfilling its responsibilities under the 

Atomic Energy Act to make a decision 

on the proposed action for 

decommissioning that ensures that 

residual radioactivity is reduced to a 

level that is protective of the public 

health and safety and the environment. 

Environmental Impacts of the Proposed 

Action 

The NRC staff reviewed the 

information provided and surveys 

performed by Saint Luke’s Hospital of 

Kansas City to demonstrate that the 

release of the Medical Plaza I Building, 

4320 Wornall Road, and the DicksonDiveley Laboratory, 4312 J.C. Nichols 

Parkway, Kansas City, Missouri 

facilities comply with radiological 

criteria for unrestricted use in 10 CFR 

20.1402. Based on its review, the staff 

has determined that the radiological 

environmental impacts from the 

proposed action are bounded by the 

‘‘Generic Environmental Impact 

Statement in Support of Rulemaking on 

Radiological Criteria for License 

Termination of NRC-Licensed Nuclear 

Facilities’’ (NUREG–1496). 

Additionally, no non-radiological or 

cumulative impacts were identified. 

Therefore, the NRC has determined that 

the proposed action will not have a 

significant effect on the quality of the 

human environment. 

Alternatives to the Proposed Action 

The only alternative to the proposed 

action of releasing the facilities for 

unrestricted use is to take no action. 

Under the no-action alternative, the 

Medical Plaza I Building and the 

Dickson-Diveley Laboratory facilities 

would remain under an NRC license 

and would not be released for 

unrestricted use. Denial of the license 

amendment request would result in no 

change to current conditions at the 

facilities. The no-action alternative is 

not acceptable because it is inconsistent 

with the NRC’s Timeliness Rule, 10 CFR 

Part 30.36, ‘‘Expiration and Termination 

of Licenses and Decommissioning of 

Sites and Separate Buildings or Outdoor 

Areas,’’ which requires licensees who 

have ceased licensed activities to 

request termination of their radioactive 

materials license. This alternative also 

would impose an unnecessary 

regulatory burden and limit potential 

benefits from future uses of the 

facilities. 

Conclusion 

The NRC staff concluded that the 

proposed action is consistent with the 

NRC’s unrestricted use specified in 10 

CFR part 20, subpart E. Since the 

proposed action will not significantly 

impact the quality of the human 

environment, the NRC staff concludes 

that the proposed action is the preferred 

alternative. 

Agencies and Persons Consulted 

The NRC staff has determined that the 

proposed action will not affect listed 

species or critical habitats. Therefore, no 

further consultation is required under 

Section 7 of the Endangered Species 

Act. Likewise, the NRC staff has 

determined that the proposed action is 

not a type of activity that has potential 

to cause effect on historic properties. 

Therefore, consultation under Section 

106 of the National Historic 

Preservation Act is not required. The 

NRC consulted with the Missouri 

Section for Environmental Public 

Health, Department of Health and 

Senior Services. The Missouri Section 

for Environmental Public Health was 

provided with the draft EA for comment 

on September 6, 2005. The State 

reviewed the EA and responded back to 

the NRC on September 7, 2005, and did 

not have any additional comments. 

II. Finding of No Significant Impact 

On the basis of the EA in support of 

the proposed license amendment to 

release the facilities for unrestricted use, 

the NRC has determined that the 

proposed action will not have a 

significant effect on the quality of the 

55178 Federal Register / Vol. 70, No. 181 / Tuesday, September 20, 2005 / Notices 

human environment. Thus, the NRC has 

determined not to prepare an 

environmental impact statement for the 

proposed action. 

Further Information 

1. McPhee, Mark, M.D., Chief 

Operating Officer, Saint Luke’s Hospital 

of Kansas City, letter to U.S. Nuclear 

Regulatory Commission, December 1, 

2004 (ML052510691). 

2. Decommissioning Report (Final 

Status Survey Report), Saint Luke’s 

Hospital of Kansas City, Medical Plaza 

I Building, 4320 Wornall Road, and the 

Dickson-Diveley Laboratory, 4312 J.C. 

Nichols Parkway, Kansas City, Missouri 

facilities, June 21, 2005 (ML052510686). 

3. Saint Luke’s Hospital of Kansas 

City Conversation Record, dated 

September 2, 2005 (ML052510698). 

4. U.S. Nuclear Regulatory 

Commission, ‘‘Environmental Review 

Guidance for Licensing Actions 

Associated with NMSS Programs,’’

NUREG–1748, August 2003. 

5. U.S. Nuclear Regulatory 

Commission, ‘‘Generic Environmental 

Impact Statement in Support of 

Rulemaking on Radiological Criteria for 

License Termination of NRC-Licensed 

Nuclear Facilities,’’ NUREG–1496, 

August 1994. 

6. NRC, NUREG–1757, ‘‘Consolidated 

NMSS Decommissioning Guidance,’’

Volumes 1–3, September 2003. 

If you do not have access to ADAMS 

or if there are problems in accessing the 

documents located in ADAMS, contact 

the NRC Public Document Room (PDR) 

reference staff at (800) 397–4209, 

(301)415–4737 or by e-mail to 

pdr@nrc.gov. Documents may also be 

viewed electronically on the public 

computers located at the NRC’s PDR, 

O 1 F21, One White Flint North, 11555 

Rockville Pike, Rockville, MD 20852. 

The PDR reproduction contractor will 

copy documents for a fee. 

Dated at Lisle, Illinois, this 12th day of 

September 2005. 

Jamnes L. Cameron, 

Chief, Decommissioning Branch, Division of 

Nuclear Materials Safety, RIII. 

[FR Doc. 05–18664 Filed 9–19–05; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Meeting Notice 

AGENCY: U.S. Nuclear Regulatory 

Commission (NRC). 

ACTION: Notice of meeting. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission will convene a meeting of 

the Advisory Committee on the Medical 

Uses of Isotopes (ACMUI) on October 25 

and 26, 2005. A sample of agenda items 

to be discussed during the public 

sessions includes: (1) Discussion of the 

Energy policy Act of 2005, which 

provides for NRC regulation of 

accelerator-produced radioactive 

material and discrete sources of Ra–226; 

(2) Status of Specialty Board 

applications for NRC recognition; (3) 

Electronic signature in written 

directives; (4) Revision of NRC Form 

313A; (5) RIS on dose control and 

assessment; (6) Review of the medical 

events definition commission paper. To 

review the agenda, see http:// 

www.nrc.gov/reading-rm/doccollections/acmui/agenda/ or contact, 

via e-mail MSS@nrc.gov. 

Purpose: Discuss issues related to 10 

CFR part 35, Medical Use of Byproduct 

Material. 

Date and Time for Closed Session 

Meeting: October 25, 2005, from 8 a.m. 

to 10 a.m. This session will be closed so 

that NRC staff can brief the ACMUI on 

discussing information relating solely to 

internal personnel rules. 

Dates and Times for Public Meetings: 

October 25, 2005, from 10 a.m. to 5 

p.m.; and October 26, 2005, from 8 a.m. 

to 5 p.m. 

Address for Public Meetings: U.S. 

Nuclear Regulatory Commission, Two 

White Flint North Building, Room 

T2B3, 11545 Rockville Pike, Rockville, 

MD 20852–2738. 

FOR FURTHER INFORMATION CONTACT: 

Mohammad S. Saba, telephone (301) 

415–7608; e-mail MSS@nrc.gov of the 

Office of Nuclear Material Safety and 

Safeguards, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555–

0001. 

Conduct of the Meeting 

Leon S. Malmud, M.D., will chair the 

meeting. Dr. Malmud will conduct the 

meeting in a manner that will facilitate 

the orderly conduct of business. The 

following procedures apply to public 

participation in the meeting: 

1. Persons who wish to provide a 

written statement should submit a 

reproducible copy to Mohammad S. 

Saba, U.S. Nuclear Regulatory 

Commission, Mail Stop T8F03, 

Washington, DC 20555. Submittals must 

be postmarked by October 3, 2005 and 

must pertain to the topics on the agenda 

for the meeting. 

2. Questions from members of the 

public will be permitted during the 

meeting, at the discretion of the 

Chairman. 

3. The transcript and written 

comments will be available for 

inspection on NRC’s Web site (http:// 

www.nrc.gov) and at the NRC Public 

Document Room, 11555 Rockville Pike, 

Rockville, MD 20852–2738, telephone 

(800) 397–4209, on or about January 26, 

2006. This meeting will be held in 

accordance with the Atomic Energy Act 

of 1954, as amended (primarily Section 

161a); the Federal Advisory Committee 

Act (5 U.S.C. App); and the 

Commission’s regulations in Title 10, 

U.S. Code of Federal Regulations, Part 7. 

4. Attendees are requested to notify 

Mohammad S. Saba at (301) 415–7608 

of their planned attendance if special 

services, such as for the hearing 

impaired, are necessary. 

Dated at Rockville, Maryland, this 14th day 

of September, 2005. 

For the Nuclear Regulatory Commission. 

Andrew L. Bates, 

Advisory Committee Management Officer. 

[FR Doc. 05–18652 Filed 9–19–05; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Sunshine Act Meetings 

DATES: Weeks of September 19, 26, 

October 3, 10, 17, 24, 2005. 

PLACE: Commissioners’ Conference 

Room, 11555 Rockville Pike, Rockville, 

Maryland. 

STATUS: Public and Closed. 

MATTERS TO BE CONSIDERED: 

Week of September 19, 2005 

There are no meetings scheduled for 

the Week of September 19, 2005. 

Week of September 26, 2005—Tentative 

There are no meetings scheduled for 

the Week of September 26, 2005. 

Week of October 3, 2005—Tentative 

There are no meetings scheduled for 

the Week of October 3, 2005. 

Week of October 10, 2005—Tentative 

There are no meetings scheduled for 

the Week of October 10, 2005. 

Week of October 17, 2005—Tentative 

Tuesday, October 18, 2005 

9:30 a.m. Briefing on 

Decommissioning Activities and 

Status (Public Meeting) 

This meeting will be webcast live at 

the Web address—http:// 

www.nrc.gov. 

Week of October 25, 2005—Tentative 

Wednesday, October 26, 2005 

1:30 p.m. Discussion of Security Issues 

(Closed—Ex. 1)